Status:
UNKNOWN
"Escape" Phenomenon of the Antihypertensive Therapy Efficacy
Lead Sponsor:
Federal State Budgetary Institution NATIONAL MEDICAL RESEARCH CENTRE OF CARDIOLOGY NAMED AFTER ACADE
Conditions:
Arterial Hypertension
Eligibility:
All Genders
18-90 years
Brief Summary
A little attention is paid to the AHT efficacy escaping problem, which can be explained by the AHT correction simplicity and rapid achievement of the target BP level. Nevertheless, modern statistic da...
Eligibility Criteria
Inclusion
- Arterial hypertension (AH) grade 1-3, stage I-II
- High compliance during the follow-up period (≥ 85%)
- Initially achieved target office BP levels while taking 2-3-component AHT
Exclusion
- Secondary AH
- Resistant AH,
- AH III stage,
- PAP- therapy,
- type 2 diabetes mellitus,
- pregnancy
- history of low adherence to treatment
Key Trial Info
Start Date :
September 29 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2025
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT05436730
Start Date
September 29 2015
End Date
December 30 2025
Last Update
June 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oksana Mikhailova
Moscow, Russia